Results 31 to 40 of about 2,153,248 (300)

Plants regulate cellular immunity of caterpillars to an entomovirus

open access: yes, 2020
Datasets for Plants regulate cellular immunity of caterpillars to an entomovirusTHIS DATASET IS ARCHIVED AT DANS/EASY, BUT NOT ACCESSIBLE HERE.
Wang, J (via Mendeley Data)
core   +4 more sources

Vaccine-induced protection against SARS-CoV-2 requires IFN-γ-driven cellular immune response

open access: yesNature Communications, 2023
The overall success of worldwide mass vaccination in limiting the negative effect of the COVID-19 pandemics is inevitable, however, recent SARS-CoV-2 variants of concern, especially Omicron and its sub-lineages, efficiently evade humoral immunity mounted
Xiaolei Wang   +15 more
doaj   +1 more source

Cellular immunity in 24 residents with different levels of anti-RBD IgG.

open access: yes, 2023
Cellular immunity in 24 residents with different levels of anti-RBD IgG.
Juan Teja (14761826)   +8 more
core   +1 more source

InnateDB: systems biology of innate immunity and beyond—recent updates and continuing curation [PDF]

open access: yes, 2012
peer-reviewedInnateDB (http://www.innatedb.com) is an integrated analysis platform that has been specifically designed to facilitate systems-level analyses of mammalian innate immunity networks, pathways and genes.
Brinkman, Fiona S. L.   +19 more
core   +1 more source

Identification of Early Cellular Immune Factors Regulating Growth of Malaria Parasites in Humans

open access: yes, 2005
In many host-parasite systems, regulatory T cells (CD4+, CD25+, FOXP3+) have been shown to modulate cellular immunity and pathology. In this issue of Immunity, Walther et al.
F. Good, Michael
core   +1 more source

Hepatitis B: Model Systems and Therapeutic Approaches

open access: yesJournal of Immunology Research
Hepatitis B virus (HBV) infection is a major global health issue and ranks among the top causes of liver cirrhosis and hepatocellular carcinoma. Although current antiviral medications, including nucleot(s)ide analogs and interferons, could inhibit the ...
Xiaoxiao Yu   +6 more
doaj   +1 more source

Trial watch: anticancer vaccination with dendritic cells

open access: yesOncoImmunology
Dendritic cells (DCs) are critical players at the intersection of innate and adaptive immunity, making them ideal candidates for anticancer vaccine development.
Francisca Borges   +16 more
doaj   +1 more source

Biphasic Clinical Course of Pediatric Cytomegalovirus‐Associated Immune Thrombocytopenia: Early Poor Treatment Response but Favorable Long‐Term Outcomes

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Cytomegalovirus (CMV) is a recognized trigger of immune thrombocytopenia (ITP); however, its incidence and impact on disease course in children remain controversial. Therefore, we aimed to characterize the clinical course of pediatric patients with CMV‐associated ITP.
Oded Gilad   +9 more
wiley   +1 more source

Partial recovery of SARS-CoV-2 immunity after booster vaccination in renal transplant recipients

open access: yesClinical Immunology Communications, 2023
The pandemic caused by the SARS-CoV-2 coronavirus has been especially detrimental to patients with end-stage renal disease. History with other vaccines suggests that patients with renal disease may not respond adequately to the SARS-CoV-2 vaccine.
J.M. Urra   +4 more
doaj   +1 more source

“We Cannot Talk as a Family”: Complexities of Survivorship Communication Among Hispanic/Latino Young Adult Survivors of Childhood Cancer, Parents, and Clinicians

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Young adult childhood cancer survivors (YA‐CCS) have an increased risk of treatment‐related health complications throughout their lives. Lifelong survivorship care is recommended, yet many YA‐CCS experience disruptions in care during pediatric‐to‐adult transitions and do not receive recommended survivorship care.
Kevin Shanchen Pu   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy